What is NDC 49502-806?

49502-806 is the product NDC for Yupelri (revefenacin), Revefenacin 175 ug/3mL solution, listed with the FDA by Viatris Specialty LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Viatris Specialty LLC, NDC labeler code 49502. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Yupelri?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Yupelri NDC 49502-806 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)49502-806Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49502-0806Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49502-806-87	49502080687	7 POUCH in 1 CARTON (49502-806-87) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-33) / 3 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 1, 2019 · Sample package
49502-806-93	49502080693	30 POUCH in 1 CARTON (49502-806-93) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-32) / 3 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 3, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Yupelri
Generic name (nonproprietary): revefenacin
Active ingredients: Revefenacin — 175 ug/3mL
Dosage form: Solution
Route: Respiratory (Inhalation)
Labeler: Viatris Specialty LLCNDC labeler code 49502
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 210598
Marketing start: Dec 3, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 49502-806_b7b789a7-deb0-41d7-9c7d-e6cf68d1b893SPL ID b7b789a7-deb0-41d7-9c7d-e6cf68d1b893SPL set ID 6dfebf04-7c90-436a-9b16-750d3c1ee0a6RxCUI 2102779, 2102784UNII G2AE2VE07O
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N449502080687 followed by a unit qualifier and the quantity

Package 49502-0806-87. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 3, 2022.

Indications (excerpt from the label)

YUPELRI is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 49502-806

What is NDC 49502-806?: 49502-806 is the product NDC for Yupelri (revefenacin), Revefenacin 175 ug/3mL solution, listed with the FDA by Viatris Specialty LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Yupelri (Revefenacin).
What is the active ingredient?: Revefenacin.
Who is the labeler?: Viatris Specialty LLC, NDC labeler code 49502. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Yupelri?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Yupelri (Revefenacin) NDC 49502-806